Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000893713 | SCV000715098 | likely benign | not provided | 2022-06-24 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV000893713 | SCV001037666 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377248 | SCV002625368 | likely benign | Cardiovascular phenotype | 2019-03-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000893713 | SCV004701477 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ALPK3: BP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000613100 | SCV005204797 | uncertain significance | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000893713 | SCV005213347 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000613100 | SCV001921270 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000893713 | SCV001969994 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530746 | SCV004754454 | likely benign | ALPK3-related disorder | 2020-10-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |